News Formal

Novo Nordisk Follows Eli Lilly in Dropping Insulin Prices

  • 📰 WebMD
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 51%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

Danish drugmaker Novo Nordisk will reduce the U.S. list prices of some of its most widely used insulin products by as much as 75%, the company announced Tuesday.

The move comes after the U.S. government capped Medicare copays for insulin at $35 and drugmaker Eli Lilly announced earlier this month that it was adjusting prices and patient assistance programs to also keep costs at $35 a month or lower.

“We have been working to develop a sustainable path forward that balances patient affordability, market dynamics, and evolving policy changes,” said Steve Albers, Novo Nordisk senior vice president for market access and public affairs, in a Even after the reductions take effect, out-of-pocket costs will likely vary for people who have private insurance policies because copays are set by insurance companies.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

🙂

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 709. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Novo Nordisk Will Cut Insulin Cost in U.S. by Up to 75 PercentNovo Nordisk will slash the list price of several of its insulin drugs by as much as 75 percent, the company said Tuesday. Good! Thanks Biden Thank you Ozempic!
Source: thedailybeast - 🏆 307. / 63 Read more »

Novo Nordisk Will Lower Insulin Prices Up To 75%, Following Eli LillyNovo Nordisk, along with Sanofi and Eli Lilly, make up most of the U.S. insulin market.
Source: Forbes - 🏆 394. / 53 Read more »